Identification of potential molecular targets of luteolin in the treatment of hepatocellular carcinoma based on network pharmacology and transcriptome sequencing technology.

Discov Oncol · 2025 · PMC12764707 · PMID 40778996

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantP < 0.01actually significant

Comparative analysis identified 975 differentially expressed genes ( P < 0.05) between groups, with a highly significant overall difference ( P < 0.01, Fig. 6 g).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.